The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study

Mar-21

Pharmacoepidemiology Respiratory

AUTHORS : Gema Requena, Respiratory Epidemiology, GSK, 980 Great West Road, Brentford, Middlesex, TW8 9GS, UK – Email: gema.x.requena@gsk.com

JOURNAL : International Journal of Chronic Obstructive Pulmonary Disease

REFERENCE: 16:629-642

DOI : 10.2147/COPD.S291931

Read more